CHReporter · Apr 2026
Profile piece describing Bramante as a young but notable American biomanufacturing startup focused on modular GMP/manufacturing infrastructure and robotics-first operations.
Company research
Public company, workplace, funding, and market signals
Updated Jul 30, 2026
Overview
Bramante Biologics Corporation (Bramante) is a Cambridge-based, YC-backed life-sciences manufacturing startup building AI/API-first lab instruments and recombinant reagents, with an onshore CDMO angle for protein therapeutics and modular microfactories. Public materials emphasize domestic manufacturing in Massachusetts, direct engineer access, and design-partner-led deployment; no separate CEO was publicly identified in the sources reviewed.
Primary product
AI/API-first life-sciences instruments and recombinant reagents for automated/robotic labs; adjacent modular biomanufacturing microfactories for protein therapeutics.
Founded
2024
Headquarters
Cambridge, Massachusetts, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Biomanufacturing CDMO / life-sciences instruments and reagents
Open Positions
0 jobs at Bramante Biologics
No open positions
Check back later for new openings